Dosing & Uses
Dosage Forms & Strengths
otic solution (Cetraxal)
- 0.5mg/0.25mL (0.2%)/dropper
otic suspension (Otiprio)
- 60mg/mL (6%)/vial
Otitis Externa
Infection caused by susceptible isolates of Pseudomonas aeruginosa or Staphylococcus aureus
Otiprio
- Instill a one-time, single dose of 0.2 mL (12 mg) into external ear canal of each affected ear
Cetraxal
- Instill contents of 1 single-use container (delivers 0.25 mL) into affected ear BID for 7 days
Dosage Forms & Strengths
otic solution (Cetraxal)
- 0.5mg/0.25mL (0.2%)/dropper
otic suspension (Otiprio)
- 60mg/mL (6%)/vial
Otitis Externa
Infection caused by susceptible isolates of Pseudomonas aeruginosa or Staphylococcus aureus
Otiprio
- <6 months: Safety and efficacy not established
- ≥ 6 months: Instill a one-time, single dose of 0.2 mL (12 mg) to the external ear canal of each affected ear
Cetraxal
- <1 year: Safety and efficacy not established
- ≥1 year: Instill contents of 1 single-use container (delivers 0.25 mL) into affected ear BID for 7 days
Tympanostomy Tube Placement
Indicated for pediatric patients aged ≥6 months with bilateral otitis media with effusion undergoing tympanostomy tube placement
<6 months: Safety and efficacy not established
Otiprio only
- ≥6 months: Administer as a single intratympanic administration of 0.1 mL (6 mg) into each affected ear, following suctioning of the middle ear effusion
Dosing Considerations
Antimicrobial activity
- Ciprofloxacin has been shown to be active against most isolates of the following bacteria:
- Gram-positive bacteria: Staphylococcus aureus, Streptococcus pneumoniae
- Gram-negative bacteria: Haemophilus influenzae, Moraxella catarrhalis, Pseudomonas aeruginosa
Adverse Effects
1-10%
Cetraxal
- Ear pruritus (2-3%)
- Fungal ear superinfection (2-3%)
- Application site pain (2-3%)
- Headache (2-3%)
Otiprio
Otitis media with effusion
- Nasopharyngitis (5%)
- Irritability (5%)
- Rhinorrhea (3%)
Acute otitis externa
- Ear pruritus (2%)
- Headache (2%)
- Otitis media (2%)
- Ear discomfort (2%)
Warnings
Contraindications
Hypersensitivity to ciprofloxacin, quinolones or any of the component of ciprofloxacin otic
Cautions
For otic use only; not for injection, inhalation or topical ophthalmic use
Discontinue at first appearance of skin rash or any other sign of hypersensitivity
May result in overgrowth of nonsusceptible organisms, including fungi
If infection not improved within 1 week consider culture to identify microorganism
Pregnancy & Lactation
Pregnancy
Data are not available regarding use in pregnant women; owing to negligible systemic exposure associated with otic administration of ciprofloxacin, minimal risk is expected
Lactation
Ciprofloxacin is excreted in human milk with systemic administration; however, owing to negligible systemic exposure after otic administration, breastfed infants should not be affected
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Pharmacology
Mechanism of Action
Fluoroquinolone antibiotic; inhibits DNA gyrase; promotes breakage of double-stranded DNA; bactericidal
Administration
Otic Preparation
Otiprio
- 1 vial of Otiprio will supply 2 doses
- Other materials needed (for each ear treated): one 1-mL Luer lock syringe; one 18-21 gauge preparation needle; one 20-24 gauge blunt, flexible catheter or comparable administration needle; alcohol pads; optional ice pack and drape to keep vial cold
- Keep the product cold during preparation; if the suspension thickens during the preparation, place the vial back in the refrigerator
- Always hold the vial by the aluminum seal to prevent gelation
- To keep the vial cold during shaking, hold the vial by the aluminum seal to prevent gelation; shake the vial for 5-8 seconds to mix well until a visually homogenous suspension is obtained
- Using an 18-21 gauge needle, withdraw 0.3 mL of the suspension into the 1-mL syringe
- Replace the needle with a 20-24 gauge, 2-3 inch blunt, flexible needle to be used for administration
- Prime the needle leaving a dose of 0.1 mL (otitis media with effusion) or 0.2 mL (acute otitis externa)
- Repeat above steps with a new syringe for dose of second ear
Otic Administration
Otiprio
- For intratympanic or otic administration by a healthcare profession only
- Intended for single-patient use; each vial provides 2 doses
- Use within 3 hr of mixing; discard unsued portion
Cetraxal
- Warm solution by holding container in hands for at least 1 minute, to minimize dizziness caused by instillation of cold solution into ear canal
- Wash hand before use
- Patient should lie with affected ear upward and the solution instilled
- Maintain this position for at least 1 minute to facilitate penetration of drops into ear; repeat, if necessary, for opposite ear
Storage
Otiprio
- Unopened vial: Refrigerate at at 2-8ºC (36-46°F); protect from light; store in the original carton until dose preparation
- During preparation: Refrigerate at 2-8ºC (36-46°F) until prior to use to prevent thickening during preparation
-
After preparation
- Can be kept at room temperature or in the refrigerator prior to administration
- Keep syringes on their side
- Discard syringes if not administered in 3 hr
Cetraxal
- Store at controlled room temperature (15-25ºC [59-77ºF])
- Discard used containers
- Store unused containers in pouch to protect from light
Images
Formulary
Adding plans allows you to compare formulary status to other drugs in the same class.
To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.
Adding plans allows you to:
- View the formulary and any restrictions for each plan.
- Manage and view all your plans together – even plans in different states.
- Compare formulary status to other drugs in the same class.
- Access your plan list on any device – mobile or desktop.